Vasudha Pharma Chem Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ITRACONAZOLE USP, with a corresponding US DMF Number 35261.
Remarkably, this DMF maintains an Active status since its submission on October 09, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 30, 2025, and payment made on January 28, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II